Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results from a randomised, clinical trial.

Grønbæk IMB, Halkjær SI, Hansen EH, Mollerup S, Paulsen SJ, Konrad CV, Engel S, Bulinska-Balas M, Wellejus A, Haaber AB, Christensen AH, Engsbro AL, Petersen AM

Open source

DOI
10.3389/fnut.2025.1701341
Published
2025
Container
Frontiers in nutrition
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3389/fnut.2025.1701341,
  title = {Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results from a randomised, clinical trial.},
  author = {Grønbæk IMB and Halkjær SI and Hansen EH and Mollerup S and Paulsen SJ and Konrad CV and Engel S and Bulinska-Balas M and Wellejus A and Haaber AB and Christensen AH and Engsbro AL and Petersen AM},
  year = {2025},
  journal = {Frontiers in nutrition},
  doi = {10.3389/fnut.2025.1701341},
  url = {https://doi.org/10.3389/fnut.2025.1701341}
}

RIS

TY  - JOUR
TI  - Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results from a randomised, clinical trial.
AU  - Grønbæk IMB
AU  - Halkjær SI
AU  - Hansen EH
AU  - Mollerup S
AU  - Paulsen SJ
AU  - Konrad CV
AU  - Engel S
AU  - Bulinska-Balas M
AU  - Wellejus A
AU  - Haaber AB
AU  - Christensen AH
AU  - Engsbro AL
AU  - Petersen AM
PY  - 2025
JO  - Frontiers in nutrition
DO  - 10.3389/fnut.2025.1701341
UR  - https://doi.org/10.3389/fnut.2025.1701341
ER  - 

APA

IMB, G., SI, H., EH, H., S, M., SJ, P., CV, K., S, E., M, B., A, W., AB, H., AH, C., AL, E., & AM, P. (2025). Eight weeks of treatment with probiotic Bifidobacterium breve, Bif195 lowers fatigue scores in patients with diarrhoea-predominant irritable bowel syndrome: results from a randomised, clinical trial.. Frontiers in nutrition. https://doi.org/10.3389/fnut.2025.1701341

Source records